Post Date Body Has new content Topic Forum Name
Wed, 06/26/2013 - 08:51

GRACE videos from ASCO 2013 continue as Dr. Nate Pennell from Cleveland Clinic reviews the LUME Lung-1 trial presented by Reck at ASCO 2013, of Taxotere with or without nindetanib (BIBF-1120), an anti-angiogenic multikinase inhibitor, in advanced NSCLC.

You can view the video here: http://cancergrace.org/lung/2013/06/26/nindetanib-bibf1120-lume-lung-1/

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: Is nindetanib worthy of becoming a new treatment for NSCLC? - 1257544 Full Archive JimC
Fri, 06/28/2013 - 17:44

In another ASCO 2013 video roundtable, Drs. Nate Pennell, Mary Pinder, and Jack West discuss trials presented at ASCO 2013 testing the potential value of molecular marker testing to select optimal chemo for advanced non-small cell lung cancer (NSCLC).

You can view the video here: http://cancergrace.org/lung/2013/06/10/madeit-sclg-molecular-selection-…

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: Can molecular markers predict the best chemo for lung cancer? - 1257600 Full Archive JimC
Fri, 06/28/2013 - 17:56

In the newest ASCO 2013 video, Dr. Mary Pinder of Moffitt Cancer Center reviews the CUSTOM trial, in which the study of molecular markers was expanded to patients with small cell lung cancer and thymic carcinomas.

You can view the video here: http://cancergrace.org/lung/2013/06/28/custom-trial-sclc-thymic-carcino…

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: Are molecular markers just for NSCLC? - 1257602 Full Archive JimC
Wed, 07/03/2013 - 09:03

In today's ASCO 2013 video, Drs. Mary Pinder, Nate Pennell, and Jack West discuss developments with selumetinib and other MEK inhibitors as a potential target for the 20-25% of NSCLC patients with a KRAS mutation.

You can view the video here: http://cancergrace.org/lung/2013/07/03/mek-inhibitor-update-asco-2013/

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: Can we target KRAS effectively in advanced NSCLC? - 1257711 Full Archive JimC
Fri, 07/05/2013 - 10:00

More breaking news from ASCO 2013, as Drs. Nate Pennell, Mary Pinder, and Jack West discuss the START trial of L-BLP-25 (tecemotide) immunotherapy in locally advanced NSCLC.

You can view the video here: http://cancergrace.org/lung/2013/07/05/start-trial-asco-2013/

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: The START trial of immunotherapy in locally advanced NSCLC - 1257737 Full Archive JimC
Mon, 07/08/2013 - 10:23

ASCO 2013 videos continue, as Drs. Jack West, Mary Pinder, and Nate Pennell discuss options for managing acquired resistance to EGFR TKIs and ALK inhibitors in patients with advanced NSCLC and a driver mutation.

You can view the video here: http://cancergrace.org/lung/2013/07/08/acquired-resistance-targeted-rx-…

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: How do we approach acquired resistance to targeted therapies? - 1257784 Full Archive JimC
Mon, 07/08/2013 - 22:17

Just ran across this web-page for the first time tonight: http://www.lungcancerprofiles.com/lung_cancer_information.aspx

Don't know much about it, but I clicked around a bit and I like what I saw. Thought I'd share.

xoxo,
Laya

Lung Cancer Profiles Webpage - 1257790 Full Archive laya d.
Wed, 07/10/2013 - 09:30

In the latest ASCO 2013 video, Drs. Jack West, Mary Pinder, and Nate Pennell review various ways in which emerging immunotherapies could be effectively incorporated into our treatment strategies for lung cancer, potentially adding to or replacing current options.

You can view the video here: http://cancergrace.org/lung/2013/07/10/integrating-immunotherapies-into…

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: Integrating new immunotherapies into treatment for lung cancer - 1257807 Full Archive JimC
Fri, 07/12/2013 - 20:54

In today's ASCO 2013 video presentation, Drs. Mary Pinder, Nate Pennell, and Jack West discuss whether the finding of improving progression-free survival with maintenance sorafenib for SCLC should change the standard of care for treatment of extensive stage disease.

You can view the video here: http://cancergrace.org/lung/2013/07/12/maintenance-sorafenib-in-ed-sclc…

We welcome your questions and comments here.

JimC
Forum moderator

ASCO 2013 Video: A role for maintenance therapy in extensive stage SCLC? - 1257882 Full Archive JimC
Fri, 11/29/2013 - 20:02

I just wrote a post about questions I had after seeing the excellent movie "Dallas Buyers Club", about how patients and caregivers really feel about the clinical trials system. The post is here:

http://cancergrace.org/general/2013/11/29/is-the-system-of-clinical-tri…

I'd welcome your honest thoughts about whether people trying to navigate in a world of of promising but also potentially dangerous new drugs for a dire medical illness feel that the system works in their best interests or works more against them.

Thanks for any input you have. I'd love comments here, after the post in the link above, or join us for the #LCSM tweet chat Thursday at 8 PM Eastern, 5 PM Pacific, if you do the Twitter thing...

-Dr. West

Does the clinical trial system work for patients and caregivers? - 1260756 Full Archive Dr West